Summary & Overview
CPT 32553: Percutaneous Chest Tumor Marker Placement
CPT code 32553 represents percutaneous placement of one or more markers into tumor tissue in the chest to guide radiation therapy. This procedure supports precise tumor localization for planning and delivery of radiotherapy, which can reduce targeting error and help spare surrounding healthy tissue. Nationally, marker placement is an important adjunct to modern image-guided radiation therapy workflows and has implications for care coordination between interventional radiology and radiation oncology. Key payers addressed in this coverage analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for marker placement, typical sites of service, and payer coverage considerations. The publication summarizes common billing modifiers and coding relationships where available, highlights typical documentation elements required to support medical necessity, and notes how this service integrates into radiation therapy planning pathways. Data not available in the input is indicated where applicable.
Billing Code Overview
CPT code 32553 describes a procedure in which one or more fiducial markers or similar markers are placed percutaneously through the skin and into tumor tissue in the chest region. These markers serve as reference points for planning and delivering radiation therapy, helping to localize tumors during treatment.
-
Service type: Image-guided percutaneous marker placement for radiation therapy planning and targeting
-
Typical site of service: Outpatient interventional radiology suite or radiation oncology procedural area
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a newly diagnosed or suspected pulmonary malignancy referred for CT-guided percutaneous fiducial marker placement (CPT 32553) to assist with image-guided radiation therapy planning and tumor localization. The patient arrives to an outpatient interventional radiology suite after multidisciplinary tumor board or radiation oncology consultation. Pre-procedure steps include review of prior chest imaging (CT or PET-CT), verification of coagulation status and medication reconciliation (anticoagulant management per institutional policy), informed consent specific to percutaneous chest procedures, and positioning for optimal CT or fluoroscopic access. Under moderate sedation or monitored anesthesia care, the interventional radiologist uses CT guidance to advance one or more percutaneous needles through the chest wall into the lung tumor or adjacent tumor bed and deploys radiopaque fiducial markers. Post-placement CT confirms marker position and screens for pneumothorax; small pneumothorax is observed and managed conservatively, whereas larger pneumothorax may require chest tube placement. The patient is observed for a few hours and discharged with radiation oncology follow-up for simulation and treatment planning using the implanted markers as a localization reference.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician professional portion if technical component billed separately. |